According to Transgene SA's latest financial reports the company's current EPS (TTM) is -$4.07. In 2022 the company made an earnings per share (EPS) of -$0.60 a decrease over its 2021 EPS that were of -$0.40.
Year | EPS | Change |
---|---|---|
2022 | -$0.60 | 48.16% |
2021 | -$0.40 | -6.93% |
2020 | -$0.43 | -0.6% |
2019 | -$0.44 | -273.41% |
2018 | $0.25 | -124.48% |
2017 | -$1.03 | 31.82% |
2016 | -$0.78 | -63.87% |
2015 | -$2.16 | -14.59% |
2014 | -$2.53 | -17.15% |
2013 | -$3.05 | 2.99% |
2012 | -$2.97 | 0.3% |
2011 | -$2.96 | 8.93% |
2010 | -$2.71 | -7.32% |
2009 | -$2.93 | 56.96% |
2008 | -$1.87 | 176.84% |
2007 | -$0.67 | -77.81% |
2006 | -$3.04 | -14.55% |
2005 (TTM) | -$3.55 | -29.41% |
2004 | -$5.04 | 18.71% |
2003 | -$4.24 | 35.08% |
2002 | -$3.14 | -16.55% |
2001 | -$3.76 | -37.1% |
2000 | -$5.98 | 13.45% |
1999 | -$5.27 | -60.26% |
1998 | -$13.27 | 109.21% |
1997 | -$6.34 |